stockrow
Monday 2 November 2026
Export CLX’s income statement to Excel — free account
The Clorox Company
CLX Consumer Defensive Household & Personal Products
The Clorox Company’s revenue for fiscal 2026 (year ended June 2026) was $6.7 billion, down 5.41% from fiscal 2025.
- Revenue
- +33.3%
- EPS
- +113.9%
- Free cash flow
- +11.4%
- Total debt
- +60.2%
Quarter to September 2026, against a year earlier
90.05
2.05
+2.33%
Follow CLX
Alert me
| Sep '26 From the 10-Q filed 2 Nov | Jun '26 | Mar '26 | Dec '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
14.57 | 19.80 | 16.77 | 16.40 |
+8 more quarters Free account |
P/S ratio |
1.37 | 1.73 | 1.86 | 1.81 | |
P/FCF ratio |
21.75 | 28.70 | 33.10 | 15.76 | |
P/Operating CF |
68.90 | 35.22 | (103.09) | 39.42 | |
P/B ratio |
81.42 | 46.12 | 136.70 | 350.32 | |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Sales |
1.90 | 2.30 | 2.12 | 2.21 | |
EV/EBITDA |
11.77 | 13.33 | 10.96 | 11.90 | |
EV/Operating CF |
20.62 | 25.26 | 24.85 | 15.20 | |
EV/FCF |
30.14 | 38.18 | 37.66 | 19.22 | |
Quick Ratio |
0.31 | 0.34 | 0.59 | 0.38 | |
Current Ratio |
0.65 | 0.66 | 0.84 | 0.74 | |
Net Debt/EBITDA |
0.00 | 11.43 | 3.75 | 7.63 | |
Debt/Assets |
50.84% | 51.09% | 38.64% | 44.29% | |
Debt/Equity |
32.91 | 15.80 | 27.03 | 71.03 | |
Asset Turnover |
1.08 | 1.01 | 1.13 | 1.21 | |
Operating CF/Net income |
0.84 | 2.02 | (0.65) | 1.98 | |
Capex/Depreciation |
(0.51) | (1.10) | (0.74) | (0.76) | |
Interest Coverage |
0.00 | 4.69 | 10.70 | 9.64 | |
Research and Development Expense of Revenue |
1.52% | 1.64% | 1.62% | 1.73% | |
Selling, General and Administrative Expense of Revenue |
25.20% | 26.39% | 24.31% | 27.02% | |
Intangible Assets out of Total Assets |
0.00 | 0.45 | 0.28 | 0.32 | |
Share Based Compensation of Revenue |
0.47% | (0.05%) | 0.90% | 1.43% | |
Graham Net Nets |
(0.59) | (0.49) | (0.29) | (0.31) | |
Graham Number |
11.16 | 14.98 | 10.27 | 6.31 | |
Earnings Yield |
6.86% | 5.05% | 5.96% | 6.10% | |
Free Cash Flow Yield |
4.60% | 3.48% | 3.02% | 6.35% | |
Revenue per Share |
15.66 | 16.00 | 13.76 | 13.76 | |
Operating CF per Share |
1.18 | 2.71 | (1.01) | 2.56 | |
Capex per Share |
(0.31) | (0.71) | (0.35) | (0.35) | |
Free Cash Flow per Share |
0.86 | 2.00 | (1.36) | 2.21 | |
Cash per Share |
1.51 | 1.17 | 9.78 | 1.87 | |
Shareholders Equity per Share |
0.99 | 2.07 | 0.76 | 0.29 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
0.99 | 2.07 | 0.76 | 0.29 | |
Free Cash Flow |
105.00 | 244.00 | (165.00) | 269.00 | |
Working Capital |
(1,023.00) | (949.00) | (504.00) | (619.00) | |
Capital Expenditures |
(38.00) | (86.00) | (43.00) | (42.00) | |
Net Current Asset Value |
(5,780.00) | (5,718.00) | (3,693.00) | (3,850.00) | |
EV/EBIT |
14.95 | 16.93 | 13.25 | 14.46 | |
Capex to Sales |
0.02 | 0.04 | 0.03 | 0.03 | |
Price to Operating Income |
10.79 | 12.73 | 11.65 | 11.86 | |
| Other line items | |||||
Average Receivables |
724.00 | 806.00 | 634.00 | 637.00 | |
Average Payables |
1,808.00 | 1,714.00 | 1,747.50 | 1,708.50 | |
Average Inventory |
675.50 | 650.00 | 611.50 | 600.00 | |
Average Assets |
6,680.00 | 6,677.50 | 5,974.00 | 5,595.00 | |
Average Common Equity |
129.50 | 367.00 | 141.00 | 78.00 |
Columns are period end dates · fundamentals updated 2 Nov 2026